1-3 of 3
John J. Powers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sézary syndrome originates from heavily mutated hematopoietic progenitors

Carly M. Harro, Kimberly B. Sprenger, Ricardo A. Chaurio, John J. Powers, Patrick Innamarato, Carmen M. Anadon, Yumeng Zhang, Subir Biswas, Gunjan Mandal, Jessica A. Mine, Carla Cortina, Mate Z. Nagy, Alexandra L. Martin, Katelyn F. Handley, Gustavo J. Borjas, Pei-Ling Chen, Javier Pinilla-Ibarz, Lubomir Sokol, Xiaoqing Yu, Jose R. Conejo-Garcia
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5586–5602.
https://doi.org/10.1182/bloodadvances.2022008562
Published: 2023
Includes: Supplemental data
Journal Articles

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Kamira Maharaj, John J. Powers, Alex Achille, Melanie Mediavilla-Varela, Wael Gamal, Karen L. Burger, Renee Fonseca, Kun Jiang, Hari P. Miskin, Dave Maryanski, Andrii Monastyrskyi, Derek R. Duckett, William R. Roush, John L. Cleveland, Eva Sahakian, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3072–3084.
https://doi.org/10.1182/bloodadvances.2020001800
Published: 2020
Includes: Supplemental data
Journal Articles

Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia

Kamira Maharaj, John J. Powers, Alex Achille, Susan Deng, Renee Fonseca, Mibel Pabon-Saldana, Steven N. Quayle, Simon S. Jones, Alejandro Villagra, Eduardo M. Sotomayor, Eva Sahakian, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2018) 2 (21): 3012–3024.
https://doi.org/10.1182/bloodadvances.2018020065
Published: 2018
Includes: Supplemental data